Allele typing of human TNFA 5'-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): Linkage disequilibrium with HLA class I and class II genes in Japanese

Tissue Antigens

Volumn 54, Issue 5, 1999, Pages 478-484

  Matsushita, M ^a,b   Tsuchiya, Naoyuki ^a   Nakayama, T ^a   Ohashi, J ^a   Shibue, T ^a   Shiota, M ^a   Oka, T ^b   Yamane, A ^b   Tokunaga, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

HLA; Linkage disequilibrium; PCR PHFA; Polymorphism; Promoter; Tumor necrosis factor

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; ASSAY; DNA FLANKING REGION; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; JAPAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

5' UNTRANSLATED REGIONS; ALLELES; GENOTYPE; HAPLOTYPES; HLA-A ANTIGENS; HLA-DR ANTIGENS; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032722277     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.540505.x     Document Type: Article

References (36)

1. Eigler A, Sinha B, Hartmaan G, Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 1997: 18: 487-92.
2. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993: 177: 557-60.
3. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994: 39: 150-4.
4. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature 1994: 371: 508-10.
5. Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995: 182: 1259-64.
6. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997: 94: 3195-9.
7. Hajeer AH, Worthington J, Silman AJ, Oilier WE. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996: 39: 1109-14.
8. Mulcahy B, Waldron-Lynch F, McDermott MF et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996: 59: 676-83.
9. Höhler T, Schäper T, Schneider PM, Meyer zum Buschenfelde KH, Marker-Hermann E. Association of different tumor necrosis factor α promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998: 41: 1489-92.
10. Kaijzel EL, Brinkman BM, van Krugten MV et al. Polymorphism within the tumor necrosis factor α (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol 1999: 60: 140-4.
11. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998:51: 605-12.
12. Uglialoro AM, Turbay D, Pesavento PA et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens 1998: 52: 359-67.
13. Hohjoh H, Nakayama T, Ohashi J et al. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-α) gene promoter with human narcolepsy. Tissue Antigens 1999: in press.
14. Tokunaga K, Ishikawa Y, Ogawa A et al. Sequence.based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997: 46: 199-205.
15. Oka T, Matsunaga H, Tokunaga K, Mitsunaga S, Juji T, Yamane A. A simple method for detecting single base substitutions and its application to HLA-DPB1 typing. Nucleic Adds Res 1994: 22: 1541-7.
16. Fujiwara K, Isa K, Oka T et al. Large-scale DNA typing for human platelet alloantigens by PCR-PHFA (preferential homoduplex formation assay). Br J Heamatol 1996: 95: 198-203.
17. Fujiwara K, Watanabe Y, Mitsunaga S et al. Determination of granulocyte-specific antigens on neutrophil Fcγ receptor IIIb by PCR-PHFA (preferential homoduplex formation assay) and gene frequencies in the Japanese population. Vox Sanguinis 1999: in press.
18. Hatta Y, Tsuchiya N, Ohashi J et al. Association of Fey receptor IIIB, but not of Fcγ receptor IIA and IIIA, polymorphisms with systemic lupus erythematosus in Japanese. Genes and Immunity 1999: in press.
19. Imanishi T, Akaza T, Kimura A, Tokunaga K, Cojobori T. Estimation of allele and haplotype frequencies for HLA and complement loci. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991 Vol. 1. Oxford: Oxford University Press, 1992: 76-9.
20. Rudin CM, Thompson CB. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med 1997: 48: 267-81.
21. Peraldi P, Spiegelman B. TNF-α and insulin resistance: summary and future prospects. Mol Cell Biochem 1998: 182: 169-75.
22. Krueger JM, Fang J, Taishi P, Chen Z, Kushikata T, Gardi J. Sleep. A physiologic role for IL-1 β and TNF-α. Ann N Y Acad Sci 1998: 856: 148-59.
23. Mimura G, Kids K, Murakami K. A multicenter study on HLA and autoimmunity in Japanese patients with early-onset insulin-dependent diabetes mellitus (IDDM): the JDS Study. Diabetes Res Clin Pract 1994: 24 (Suppl): S75-81.
24. Watanabe Y, Tokunaga K, Matsuki K et al. Putative amino acid sequence of HLA-DRB chain contributing to rheumatoid arthritis susceptibility. J Exp Med 1989: 169: 2263-8.
25. Wakitani S, Imoto K, Murata N, Toda Y, Ogawa R, Ochi T. The homozygote of HLA-DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese. Stand J Rheumatol 1998: 27: 381-2.
26. Saeki H, Kuwata S, Nakagawa H et al. Analysis of disease-associated amino acid epitopes on HLA class II molecules in atopic dermatitis. J Allergy Clin Immunol 1995: 96: 1061-8.
27. Romagnani P, Annunziato F, Baccari MC, Parronchi P. T cells and cytokines in Crohn's disease. Curr Opin Immunol 1997: 9: 793-9.
28. Nakajima A, Matsuhashi N, Kodama T et al. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995: 109: 1462-7.
29. Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 1999: 53: 350-8.
30. Giacomelli R, Passacantando A, Parzanese I et al. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD). Clin Exp Immunol 1998: 111: 532-5.
31. Futami S, Aoyama N, Honsako Y et al. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 1995: 40: 814-8.
32. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immonol 1994: 56: 389-466.
33. Zanelli E, Huizinga TWJ, Guerne P-A et al. An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition. Immunogenetics 1998: 48: 394-401.
34. Wakitani S, Murata N, Toda Y et al. The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. Brit J Rheumatol 1997: 36: 630-6.
35. Higami K, Hakoda M, Matsuda Y, Ueda H, Kashiwazaki S. Lack of association of HLA-DRB1 genotype with radiographic progression in japanese patients with early rheumatoid arthritis. Arthritis Rheum 1997: 40: 2241-7.
36. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extra-articular manifestations in rheumatoid arthritis. J Clin Invest 1992: 89: 2033-9.